Log in | Register

Single-Use Bioreactor Eliminates Downtime And Increases Throughput

For the latest pharmaceutical news and updates - Sign up now!
Loading...
Single-Use Bioreactor Eliminates Downtime And Increases Throughput


The Mobius CellReady 3L Bioreactor is a ready-to-use three-liter bioreactor that demonstrates all the benefits typically associated with single-use processing, while incorporating standard design features familiar to users already using benchtop, stirred-tank bioreactors. Designed to replace traditional glass benchtop bioreactors, the CellReady 3L Bioreactor has a standard stirred-tank format for use in development and optimization of cell culture processes. This vessel design provides a higher degree of predictability during process scale-up when compared to formats utilizing alternative vessel designs and agitation methods. It features a universal design, ensuring compatibility with most benchtop bioreactor control systems. By eliminating time-consuming steps associated with cleaning, assembly, and sterilization, the CellReady 3L bioreactor significantly reduces the turnaround time typically associated with glass bioreactors.

Register or log in to send e-mail for more info

E-mail to a colleague

See company's other products

Millipore Corporation
290 Concord Road
Billerica, MA, 01821
Phone: 800-MILLIPORE
Fax: 978-715-1393

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter